To better understand developmental changes in BTHS patient neutrophils, we performed tandem mass tag (TMT) proteomic analysis of circulating neutrophils from patients (n = 4 G-CSF-treated and n = 1 untreated, non-neutropenic patient), as well as healthy controls (n = 5). This evidence concerns the gene CSF3 and Barth syndrome.